The Future of ART Regimens for HIV Is in Long-Acting Agents

By News Health
3 weeks Ago

(MedPage Today) — Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don’t require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard triple-drug regimens.
The…

Source link : https://www.medpagetoday.com/spotlight/hiv/116814

Author :

Publish date : 2025-08-04 17:18:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

New Guidance Released on VEXAS Diagnosis and Management

I Was Inside CDC During the Shooting. I Can Still Hear the Bullets.

Med School Diversity Fell After Supreme Court Affirmative Action Ruling

JWST gets a closer look at interstellar comet 3I/ATLAS

1 in 3 Childhood Cancer Survivors in LATAM Lack Follow-Up

Major Hospital Dumps United Healthcare; Fewer Qualified Docs; Alcohol and Hair Loss